West Pharmaceutical Services, Inc.WSTNYSE
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank43
3Y CAGR-13.5%
5Y CAGR-11.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-13.5%/yr
vs +25.7%/yr prior
5Y CAGR
-11.6%/yr
Consistent
Acceleration
-39.2pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 15.52% |
| 2024 | -15.85% |
| 2023 | 7.25% |
| 2022 | 23.97% |
| 2021 | 23.60% |
| 2020 | 28.68% |
| 2019 | 27.23% |
| 2018 | 9.61% |
| 2017 | 20.01% |
| 2016 | 3.30% |